Measure ID: MIPS 385|Ophthalmology|2026 Performance Year

Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement

Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye.

Outcome – High PriorityOphthalmologyPatient Safety

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

Patients aged ≥ 18 years on the date of the procedure
ANDPatient procedure during the performance period

Denominator Exclusions2

M1453Patients with a pre-operative visual acuity better than 20/40
G9757Surgical procedures that included the use of silicone oil

Numerator

Patients who achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye.

Submission Codes (QDCs)

✓ Performance Met
G9516Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery
✗ Performance Not Met
G9517Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

Denominator Exceptions

None — this measure has no denominator exceptions.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

Did the patient's vision improve after retinal detachment surgery? This measures whether your surgical outcomes actually restored function—not just reattached the retina, but improved visual acuity within 90 days. Improvement happens when you use modern surgical techniques, achieve solid reattachment, and manage postoperative inflammation well. Visual improvement is the outcome that matters to patients; it justifies the surgery and reduces the psychological burden of vision loss.

📖Clinical Rationale

For management and treatment for PVD and RRD, the following apply (for goals of treatment): • Prevention of visual loss and functional impairment • Maintenance of quality of life All patients with risk factors should be instructed to notify their ophthalmologist as soon as possible if they have a substantial change in symptoms, such as an increase in floaters, loss of visual field, or decrease in visual acuity develop.

Studies demonstrate that the success rate increases with the recognition of risk factors and the practice of retina subspecialization. International studies report primary rhegmatogenous retinal surgery success rates ranging from 64 to 91%.

📝Clinical Recommendations

This is an outcome measure. As such, no clinical recommendations are included.

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this procedure measure is submitted each time a procedure is performed. This is an outcome measure and will be calculated solely using MIPS eligible clinician, group, or third-party intermediary submitted data.

• For patients who receive the surgical procedures specified in the denominator coding, it should be submitted whether or not the patient achieved an improvement of their visual acuity within 90 days of surgery. • Include only procedures performed between January 1st and September 30th of the performance period. This will allow the post-operative period to occur before third-party intermediaries must submit data to CMS.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
© 2015-2025 American Academy of Ophthalmology. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to